Medicine
Betamethasone dipropionate 0.5 mg/g topical spray
Betamethasone dipropionate 0.5 mg/g topical spray is a generic prescription medicine for topical use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Betamethasone dipropionate
- Brand
- Sold under the generic name
- Strength
- 0.5 mg/g
- Dosage form
- Topical spray
- Route
- Topical
- Packs
- 1 bottle
- Manufacturer
- Sun Pharmaceutical IndustriesIndia
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 June 2020
- Identifiers
- RxCUI 1738536DailyMed set ID dc3dd2f7-38ad-4c4c-8602-29b33cc6af90NDC 51672-1390Application ANDA211722
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 60 g in 1 bottle | 51672-1390-4 | Sun Pharmaceutical IndustriesIndia | 17 June 2020 |
| 1 bottle in 1 carton / 120 g in 1 bottle | 51672-1390-8 | Sun Pharmaceutical IndustriesIndia | 17 June 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 January 1975 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Betamethasone dipropionate 0.5 mg/g topical spray.
Other strengths and forms of Betamethasone dipropionate
Clinical summary
Betamethasone dipropionate is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. MedsAcross supplies Betamethasone dipropionate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Betamethasone dipropionateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Betamethasone Dipropionate prescribing information (Prasco Laboratories) · U.S. National Library of Medicine, DailyMed
Need Betamethasone dipropionate 0.5 mg/g topical spray for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.